|Bid||0.0000 x 800|
|Ask||0.0000 x 900|
|Day's Range||1.3600 - 1.5300|
|52 Week Range||1.3600 - 5.2000|
|Beta (5Y Monthly)||0.72|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for ORGS
We feel now is a pretty good time to analyse Orgenesis Inc.'s ( NASDAQ:ORGS ) business as it appears the company may be...
Orgenesis plans to open the Maryland Center for Cell Therapy Manufacturing on Johns Hopkins' East Baltimore medical campus.
While it may not be enough for some shareholders, we think it is good to see the Orgenesis Inc. ( NASDAQ:ORGS ) share...